RRoche Read More Roche (RHHBY) Partners with Defand Therapeutics in $1 Billion On2026-10-09 On October 08, 2026, Roche Holding AG (OTCPK: RHHBY) announced a strategic partnership with Chinese biotech startup Defand…
RRoche Read More Roche Stocks: Genentech Commits $100 Million Upfront in Potentia2026-10-08 Roche Holding, the Swiss pharmaceutical group (RO), committed $100 million upfront through Genentech to license Alector’s experimental Parkinson’s…
RRoche Read More Roche Drops as Phase 3 Kidney Signal Needs Two-Year Proof2026-09-30 This article first appeared on GuruFocus. Roche Holding (RHHBY), the pharmaceuticals and diagnostics group, reported that its experimental…
UUBS Read More PAGS Maintained by UBS — Price Target Lowered to $11.002026-09-29 On October 23, 2023, PagSeguro Digital PAGS received an updated rating from UBS analyst Kaio Prato, who maintained…
UUBS Read More CoreWeave Lands Fresh Wall Street Vote of Confidence as UBS Sets $120 Target2026-09-24 This article first appeared on GuruFocus. CoreWeave is drawing fresh attention from Wall Street after UBS began covering…
UUBS Read More CoreWeave Lands Fresh Wall Street Vote of Confidence as UBS Sets2026-09-24 CoreWeave is drawing fresh attention from Wall Street after UBS began covering the AI infrastructure provider with a…
RRoche Read More Roche Drops as Phase 3 Kidney Signal Needs Two-Year Proof2026-09-24 This article first appeared on GuruFocus. Roche Holding (RHHBY), the pharmaceuticals and diagnostics group, reported that its experimental…
UUBS Read More UBS Delivers Bullish Call on 10 Stocks With Up to 62% Upside2026-09-17 This article first appeared on GuruFocus. UBS has highlighted 10 industrial companies it sees as positioned for a…
NNovartis Read More Novartis Rebounds as $30 Billion Wipeout Draws Board Challenge2026-09-10 This article first appeared on GuruFocus. Novartis (NYSE:NVS), the Swiss pharmaceutical group, rebounded 0.8% to $138.545 Thursday as…
NNovartis Read More Novartis Rebounds as $30 Billion Wipeout Draws Board Challenge2026-09-10 This article first appeared on GuruFocus. Novartis (NYSE:NVS), the Swiss pharmaceutical group, rebounded 0.8% to $138.545 Thursday as…
NNovartis Read More Novartis Crashes 13.5% After $12 Billion Deal’s Lead Drug Fails2026-09-09 This article first appeared on GuruFocus. Novartis (NYSE:NVS), the Swiss pharmaceutical giant, absorbed a brutal setback Tuesday after…
UUBS Read More UBS Stays Flat After Flipping From Zero Fed Hikes to Two2026-09-07 This article first appeared on GuruFocus. UBS Group (NYSE:UBS), the global wealth-management and investment-banking powerhouse, flipped its Federal…